XORTX Historical Financial Ratios

XRTX Stock  USD 1.19  0.03  2.59%   
XORTX Therapeutics is currently reporting on over 87 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0, PTB Ratio of 0.89 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate XORTX Therapeutics financial condition quickly.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

About XORTX Financial Ratios Analysis

XORTX TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate XORTX Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on XORTX financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across XORTX Therapeutics history.

XORTX Therapeutics Financial Ratios Chart

At this time, XORTX Therapeutics' Payables Turnover is fairly stable compared to the past year. Cash Per Share is likely to rise to 2.09 in 2024, whereas PTB Ratio is likely to drop 0.89 in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.
Most ratios from XORTX Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.At this time, XORTX Therapeutics' Payables Turnover is fairly stable compared to the past year. Cash Per Share is likely to rise to 2.09 in 2024, whereas PTB Ratio is likely to drop 0.89 in 2024.

XORTX Therapeutics fundamentals Correlations

0.44-0.01-0.52-0.130.531.0-0.55-0.86-0.1-0.380.13-0.03-0.190.340.29-0.25-0.040.26-0.410.31-0.620.31-0.240.180.28
0.44-0.04-0.740.540.330.44-0.75-0.39-0.170.060.190.04-0.110.89-0.57-0.610.12-0.6-0.030.62-0.06-0.53-0.870.42-0.57
-0.01-0.040.36-0.10.46-0.010.340.30.82-0.08-0.77-0.99-0.830.03-0.330.66-0.21-0.290.84-0.440.06-0.33-0.23-0.18-0.29
-0.52-0.740.36-0.51-0.02-0.521.00.610.670.38-0.7-0.350.1-0.730.210.84-0.290.260.33-0.440.290.180.39-0.340.23
-0.130.54-0.1-0.51-0.4-0.13-0.45-0.05-0.35-0.170.380.13-0.090.58-0.59-0.560.6-0.630.15-0.030.1-0.56-0.370.32-0.6
0.530.330.46-0.02-0.40.53-0.07-0.230.59-0.1-0.58-0.52-0.30.23-0.210.3-0.48-0.190.210.2-0.41-0.21-0.49-0.21-0.19
1.00.44-0.01-0.52-0.130.53-0.55-0.86-0.1-0.380.13-0.03-0.190.340.29-0.25-0.040.26-0.410.31-0.620.31-0.240.180.28
-0.55-0.750.341.0-0.45-0.07-0.550.630.640.34-0.68-0.320.11-0.710.190.81-0.210.240.33-0.50.290.160.4-0.370.22
-0.86-0.390.30.61-0.05-0.23-0.860.630.340.44-0.35-0.25-0.04-0.21-0.350.36-0.12-0.30.51-0.370.76-0.370.04-0.48-0.31
-0.1-0.170.820.67-0.350.59-0.10.640.340.19-1.0-0.84-0.39-0.23-0.240.85-0.41-0.190.69-0.280.01-0.25-0.2-0.21-0.2
-0.380.06-0.080.38-0.17-0.1-0.380.340.440.19-0.230.070.33-0.15-0.110.14-0.48-0.08-0.010.530.73-0.11-0.190.16-0.09
0.130.19-0.77-0.70.38-0.580.13-0.68-0.35-1.0-0.230.790.310.260.22-0.850.410.18-0.650.25-0.010.230.190.210.19
-0.030.04-0.99-0.350.13-0.52-0.03-0.32-0.25-0.840.070.790.830.020.32-0.70.310.29-0.840.380.00.330.210.160.29
-0.19-0.11-0.830.1-0.09-0.3-0.190.11-0.04-0.390.330.310.83-0.20.27-0.310.120.25-0.680.350.020.260.140.060.25
0.340.890.03-0.730.580.230.34-0.71-0.21-0.23-0.150.260.02-0.2-0.56-0.690.38-0.580.020.330.01-0.51-0.860.2-0.54
0.29-0.57-0.330.21-0.59-0.210.290.19-0.35-0.24-0.110.220.320.27-0.560.120.01.0-0.58-0.05-0.241.00.670.071.0
-0.25-0.610.660.84-0.560.3-0.250.810.360.850.14-0.85-0.7-0.31-0.690.12-0.490.160.57-0.44-0.010.080.34-0.260.13
-0.040.12-0.21-0.290.6-0.48-0.04-0.21-0.12-0.41-0.480.410.310.120.380.0-0.49-0.04-0.11-0.35-0.160.05-0.090.230.01
0.26-0.6-0.290.26-0.63-0.190.260.24-0.3-0.19-0.080.180.290.25-0.581.00.16-0.04-0.56-0.07-0.210.990.670.021.0
-0.41-0.030.840.330.150.21-0.410.330.510.69-0.01-0.65-0.84-0.680.02-0.580.57-0.11-0.56-0.410.18-0.59-0.22-0.05-0.56
0.310.62-0.44-0.44-0.030.20.31-0.5-0.37-0.280.530.250.380.350.33-0.05-0.44-0.35-0.07-0.410.08-0.03-0.450.53-0.06
-0.62-0.060.060.290.1-0.41-0.620.290.760.010.73-0.010.00.020.01-0.24-0.01-0.16-0.210.180.08-0.25-0.1-0.15-0.21
0.31-0.53-0.330.18-0.56-0.210.310.16-0.37-0.25-0.110.230.330.26-0.511.00.080.050.99-0.59-0.03-0.250.620.111.0
-0.24-0.87-0.230.39-0.37-0.49-0.240.40.04-0.2-0.190.190.210.14-0.860.670.34-0.090.67-0.22-0.45-0.10.62-0.220.63
0.180.42-0.18-0.340.32-0.210.18-0.37-0.48-0.210.160.210.160.060.20.07-0.260.230.02-0.050.53-0.150.11-0.220.06
0.28-0.57-0.290.23-0.6-0.190.280.22-0.31-0.2-0.090.190.290.25-0.541.00.130.011.0-0.56-0.06-0.211.00.630.06
Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio(47.56)9.0316.8119.250.930.89
Book Value Per Share0.55(0.36)1.712.044.712.34
Free Cash Flow Yield(0.0255)(0.0655)(0.0217)(0.066)(1.53)(1.45)
Operating Cash Flow Per Share(0.42)(0.98)(4.36)(5.96)(3.32)(3.49)
Capex To Depreciation0.350.72.230.80.450.43
Pb Ratio(47.56)9.0316.8119.250.930.89
Free Cash Flow Per Share(0.43)(1.0)(4.39)(5.99)(3.35)(3.51)
Roic3.73(1.05)(0.32)(1.53)(1.04)(0.98)
Net Income Per Share(1.06)(1.73)(1.19)(4.72)(1.44)(1.52)
Payables Turnover0.03280.06680.05520.05820.720.76
Cash Per Share0.09840.2313.567.031.742.09
Pocfratio(40.35)(15.57)(46.42)(15.22)(0.66)(0.69)
Interest Coverage(51.9)(15.21)(96.25)(941.98)(1.1K)(1.0K)
Capex To Operating Cash Flow(0.0282)(0.0197)(0.006566)(0.005015)(0.007157)(0.007515)
Pfcf Ratio(39.24)(15.27)(46.12)(15.15)(0.65)(0.69)
Days Payables Outstanding11.1K5.5K6.6K6.3K503.47478.3
Income Quality0.40.573.671.263.053.2
Roe2.97(1.02)(0.0987)(1.0)(0.62)(0.65)
Ev To Operating Cash Flow(5.03)(40.32)(15.34)(43.31)(14.05)(0.14)
Pe Ratio(15.99)(8.83)(170.33)(19.21)(1.52)(1.59)
Return On Tangible Assets(0.77)(0.62)(0.0759)(0.58)(0.54)(0.57)
Ev To Free Cash Flow(4.9)(39.21)(15.04)(43.03)(13.98)(0.14)
Earnings Yield(0.0625)(0.11)(0.005871)(0.0521)(0.66)(0.63)
Intangibles To Total Assets0.250.10.01160.01620.03210.0304
Net Debt To E B I T D A0.01360.149.081.10.530.92
Current Ratio0.631.993.817.1913.814.49
Tangible Book Value Per Share(0.81)1.3811.864.582.251.22
Graham Number2.918.1417.9522.388.728.38
Shareholders Equity Per Share0.55(0.36)1.712.044.712.34
Capex Per Share0.01180.01940.02860.02990.02380.0226
Interest Debt Per Share0.110.150.01820.0040280.0046320.004401
Enterprise Value Over E B I T D A(17.58)(8.93)(126.44)(13.17)(0.14)(0.15)
Price Earnings Ratio(15.99)(8.83)(170.33)(19.21)(1.52)(1.59)
Price Book Value Ratio(47.56)9.0316.8119.250.930.89
Price Earnings To Growth Ratio0.19(0.14)5.46(0.0648)0.02180.0207

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.